BACK
|Enrolling,Heart Failure

Comet

This trial is looking at the medication Omecamtiv Mecarbil (OM for short) in patients with severely reduced ejection fraction (pumping function less than 30%).

More Information

Capital Area Research LLC © Copyright 2025 All rights reserved.
875 Popular Church Rd. Suite 330 Camp Hill, PA - 717.963.8389